$271.03
+1.04 (+0.39%)
Analyst Consensus
Buy
31
Analysts
Very High
Coverage
Buy 22 71%
Hold 9 29%
Sell 0 0%
Price Target
Analyst Price Target +10.5% upside
Low Target $223.02
Average Target $299.55
High Target $400.15
Current Price $271.03
Current
$271.03
Target
$299.55
$223.02 $299.55 avg $400.15
Scenario Analysis
Bear Case
$223.02
-17.7%
Low target
Base Case
$299.55
+10.5%
Avg target
Bull Case
$400.15
+47.6%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$281.07
-3.6% from high
52-Week Low
$173.33
+56.4% from low
50-Day SMA
$219.25
+23.6% vs SMA
200-Day SMA
$185.17
+46.4% vs SMA
RSI (14)
88.6
Overbought
Target vs 52W High
$299.55
+6.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.0%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +10.5%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.1%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.5%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +177.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -37.9%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +193.9%